Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

981 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
Black HR, Elliott WJ, Grandits G, Grambsch P, Lucente T, White WB, Neaton JD, Grimm RH Jr, Hansson L, Lacourciere Y, Muller J, Sleight P, Weber MA, Williams G, Wittes J, Zanchetti A, Anders RJ; CONVINCE Research Group. Black HR, et al. Among authors: zanchetti a. JAMA. 2003 Apr 23-30;289(16):2073-82. doi: 10.1001/jama.289.16.2073. JAMA. 2003. PMID: 12709465 Clinical Trial.
Results of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial by geographical region.
Black HR, Elliott WJ, Grandits G, Grambsch P, Lucente T, Neaton JD, Grimm RH Jr, Hansson L, Lacourcière Y, Muller JE, Sleight P, Weber MA, White WB, Williams GH, Wittes J, Zanchetti A, Anders RJ; CONVINCE Research Group. Black HR, et al. Among authors: zanchetti a. J Hypertens. 2005 May;23(5):1099-106. doi: 10.1097/01.hjh.0000166853.26087.22. J Hypertens. 2005. PMID: 15834298 Clinical Trial.
Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial.
Black HR, Elliott WJ, Neaton JD, Grandits G, Grambsch P, Grimm RH Jr, Hansson L, Lacoucière Y, Muller J, Sleight P, Weber MA, White WB, Williams G, Wittes J, Zanchetti A, Fakouhi TD, Anders RJ. Black HR, et al. Among authors: zanchetti a. Hypertension. 2001 Jan;37(1):12-18. doi: 10.1161/01.hyp.37.1.12. Hypertension. 2001. PMID: 11208750
Rationale and design for the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) Trial.
Black HR, Elliott WJ, Neaton JD, Grandits G, Grambsch P, Grimm RH Jr, Hansson L, Lacoucière Y, Muller J, Sleight P, Weber MA, White WB, Williams G, Wittes J, Zanchetti A, Fakouhi TD. Black HR, et al. Among authors: zanchetti a. Control Clin Trials. 1998 Aug;19(4):370-90. doi: 10.1016/s0197-2456(98)00013-0. Control Clin Trials. 1998. PMID: 9683312 Clinical Trial.
The first report of the Systolic and Pulse Pressure (SYPP) Working Group.
Black HR, Kuller LH, O'Rourke MF, Weber MA, Alderman MH, Benetos A, Burnett J, Cohn JN, Franklin SS, Mancia G, Safar M, Zanchetti A. Black HR, et al. Among authors: zanchetti a. J Hypertens Suppl. 1999 Dec;17(5):S3-14. J Hypertens Suppl. 1999. PMID: 10706319 Review. No abstract available.
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.
Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, Hua T, Laragh J, McInnes GT, Mitchell L, Plat F, Schork A, Smith B, Zanchetti A; VALUE trial group. Julius S, et al. Among authors: zanchetti a. Lancet. 2004 Jun 19;363(9426):2022-31. doi: 10.1016/S0140-6736(04)16451-9. Lancet. 2004. PMID: 15207952 Clinical Trial.
981 results